Why the study?
Right heart catheterization is invasive and unsuitable for screening or monitoring right ventricular hemodynamics in pulmonary hypertension, highlighting the need for practical noninvasive echocardiographic methods.
Key points are not available for this paper at this time.
Design
Review
May aid noninvasive PH hemodynamic screening when RHC is impractical; leaves open outcome-validated thresholds before practice change.
Pulmonary hypertension (PH) is a debilitating condition defined as mean pulmonary arterial pressure (mPAP) ≥ 25 mmHg. The importance of impaired right ventricular (RV) hemodynamics is increasingly being recognized in treatment of patients with PH. In World Health Organization Group 1 patients with pulmonary arterial hypertension, upfront combination therapy has recently been proposed to improve long-term survival. Also, the mPAP in Group 2 and 3 PH patients has been shown to be strongly associated with clinical outcomes. Thus, screening and monitoring of RV hemodynamics are becoming increasingly important. The gold standard for measuring RV hemodynamics is right heart catheterization (RHC). Although RHC can obtain the most accurate results, it is invasive, cumbersome to patients, and often associated with complications, making it unsuitable for a screening or monitoring modality. Echocardiography is useful in estimating hemodynamic parameters that can be obtained from RHC. Accordingly, the role of echocardiography in evaluating such patients with PH is becoming more important. In this article, we review practical echocardiographic methods in approximating RV hemodynamics for PH.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: